You are here: Industry Insights > Marketing

News List

Long-acting Aripiprazole for Injection Developed by Otsuka Pharmaceutical Gain Approval in China Caicai/PharmaSources
June 06, 2023
On May 23, the NMPA official website revealed that Aripiprazole (Aripiprazole long-acting intramuscular injection) developed by Otsuka Pharmaceutical to treat schizophrenia was approved for marketing.
ProBioGen’s Growth Strategy Continues Successfully PharmaSources
March 06, 2023
In line with this growth, three crucial positions have been filled. These appointments reflect the company's commitment to continued growth.
Best-sellers among the 20 Chinese-produced Class 1 New Drugs Marketed Since 2018 PharmaSources/Caicai
April 21, 2020
Class 1 new drugs, Chinese-produced, marketing.According to statistics, the NMPA approved the marketing of 13 Class 1 new drugs and 17 biological products in the 17 years from 2001 to 2017. The number of innovative drugs approved was pitifully small.
Harvest in 2019 year-end with the Marketing of Multiple Generic Drugs PharmaSources/Caicai
January 07, 2020
The NMPA is also “sprinting” as the year is coming to an end.
Competition in the RMB3 Billion Psoriasis Drug Market Turning White-hot! PharmaSources/Caicai
July 10, 2019
J & J’s “Best Psoriasis Drug” Guselkumab Applied for Marketing in China
Marketing OK'd for Device to Help Reduce IBS Symptoms in Adolescents drugs
June 12, 2019
Marketing OK'd for Device to Help Reduce IBS Symptoms in Adolescents.
Marketing OK'd for Device to Help Reduce IBS Symptoms in Adolescents drugs
June 11, 2019
Marketing OK'd for Device to Help Reduce IBS Symptoms in Adolescents.
Waylivra granted conditional marketing authorisation in Europe pharmatimes
May 09, 2019
Waylivra granted conditional marketing authorisation in Europe.
Medical marketing has ‘skyrocketed’ in the past two decades europeanpharmaceuticalreview
January 14, 2019
Medical marketing increased substantially from 1997 through 2016, especially direct-to-consumer advertising for drugs and health services…
Jubilant Appoints Director of Business Development contractpharma
December 27, 2018
Jubilant HollisterStier has named Mark Sassler as their new director of business development for the contract manufacturing and services division. Mr. Sassler will report to Lynn Allen, senior director

Previous page 1 2 Next page